\-\ Texto\\:\\ \ \(0\)\
\-\ \\Â\\»\\ \\"rock\\ hard\\"\\ left\\ testicle\\.\ \(0\)\
\-\ \\Â\\»\\ lab\\ values\\ \\-\ \(0\)\
\-\ alpha\\-fetoprotein\\:\\ 10314\\ ng\\/ml\\ \ \(0\)\
\-\ beta\\ hcg\\:\\ 89937\\ miu\\/ml\\ \ \(0\)\
\-\ ldh\\:\\ 580\\ u\\/l\ \(0\)\
\-\ t2n2m1bs3\\ \\	ajcc\\ stage\\ iiic\\ \\(poor\\ risk\\,\\ but\\ \\~70\\%\\ respond\\ to\\ initial\\ chemo\\,\\ with\\ 10\\-15\\%\\ eligible\\ for\\ salvage\\ therapy\\)\\.\ \(0\)\
\-\ screening\\ abdomen\\ and\\ chest\\ studies\\ show\\ dissemination\\ \\ \\-\\ but\\ there\\ are\\ no\\ brain\\ metastases\\.\ \(0\)\
\-\ orchiectomy\\ with\\ retroperitoneal\\ lymph\\ node\\ dissection\\,\\ was\\ followed\\ by\\ chemotherapy\\.\ \(0\)\
\-\ testicle\\ ultrasound\ \(0\)\
\-\ \\â\\€\\¢\\ well\\-circumscribed\\,\\ heterogeneously\\ hypoechoic\\ mass\\ with\\ mixed\\ solid\\ and\\ cystic\\ components\\,\\ arising\\ from\\ the\\ left\\ testicle\\ and\\ confined\\ within\\ the\\ tunica\\ albuginea\\.\ \(0\)\
\-\ abdominal\\ ct\ \(0\)\
\-\ \\â\\€\\¢\\ bulky\\ retroperitoneal\\ and\\ para\\-aortic\\ lymphadenopathy\\.\\ \\ \ \(0\)\
\-\ chest\\ film\\ and\\ ct\ \(0\)\
\-\ \\â\\€\\¢\\ supraclavicular\\ and\\ subcarinal\\ adenopathy\\ and\\ multiple\\ lung\\ nodules\\.\\ \\ \ \(0\)\
\-\ all\\ of\\ these\\ findings\\ suggest\\ a\\ metastatic\\ testicular\\ cancer\ \(0\)\
\-\ mixed\\ germ\\ cell\\ testicular\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ germ\\ cell\\ tumor\\ \\(likely\\ non\\-seminomatous\\)\ \(0\)\
\-\ \\â\\€\\¢\\ stromal\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ 20\\ y\\.o\\.\\ man\\ with\\ trauma\\ to\\ the\\ groin\\ 4\\ days\\ ago\\,\\ presents\\ with\\ increasing\\ pain\\ and\\ swelling\\ of\\ his\\ left\\ testicle\\ for\\ two\\ days\\.\ \(1\)\
\-\ lymph\\ node\\ drainage\\ from\\ the\\ testicle\\ follows\\ the\\ path\\ of\\ embryonic\\ develoment\\ back\\ to\\ the\\ renal\\ hilus\\ and\\ para\\-aortic\\ lymph\\ nodes\\.\\ \\ staging\\ of\\ testicular\\ cancers\\ includes\\ imaging\\ of\\ the\\ abdomen\\ and\\ chest\\.\\ \\ metastatic\\ spread\\ usually\\ follows\\ this\\ cascade\\:\\ local\\ lymph\\ nodes\\/veins\\ \\>\\ renal\\ and\\ para\\-aortic\\ nodes\\/veins\\ \\>\\ lung\\ \\>\\ system\\ spread\\.\\ \\ the\\ lung\\ is\\ usually\\ involved\\ before\\ there\\ can\\ be\\ spread\\ to\\ the\\ cns\\ \\-\\ unless\\ there\\ is\\ right\\-to\\-left\\ shunt\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ testicle\\:\\ 0\\.09287256666836093\ \(0\)\
\-\ para\\-aortic\\:\\ 0\\.07893840096429683\ \(0\)\
\-\ nodes\\/veins\\:\\ 0\\.06887123768723827\ \(0\)\
\-\ lymph\\:\\ 0\\.053899100139760105\ \(0\)\
\-\ testicular\\:\\ 0\\.05138322216941231\ \(0\)\
\-\ spread\\:\\ 0\\.04843813121299545\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.03672689886552862\ \(0\)\
\-\ follows\\:\\ 0\\.03590633374054993\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.03556905114785299\ \(0\)\
\-\ germ\\:\\ 0\\.03453960366635984\ \(0\)\
\-\ 10314\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ 89937\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ 580\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ t2n2m1bs3\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ ajcc\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ \\~70\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ cascade\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ \\>\\:\\ 0\\.03327149431252224\ \(0\)\
\-\ \\Â\\»\\:\\ 0\\.0328933456092063\ \(0\)\
\-\ develoment\\:\\ 0\\.03172801266955685\ \(0\)\
\-\ node\\:\\ 0\\.030548778480688037\ \(0\)\
\-\ iiic\\:\\ 0\\.03014416459100933\ \(0\)\
\-\ mixed\\:\\ 0\\.02931971399171509\ \(0\)\
\-\ hilus\\:\\ 0\\.02902040649549456\ \(0\)\
\-\ right\\-to\\-left\\:\\ 0\\.02902040649549456\ \(0\)\
\-\ lung\\:\\ 0\\.029005770940297805\ \(0\)\
\-\ salvage\\:\\ 0\\.02814875199817343\ \(0\)\
\-\ non\\-seminomatous\\:\\ 0\\.02814875199817343\ \(0\)\
\-\ rock\\:\\ 0\\.027436558416947043\ \(0\)\
\-\ eligible\\:\\ 0\\.026834407323871816\ \(0\)\
\-\ albuginea\\:\\ 0\\.026834407323871816\ \(0\)\
\-\ dissemination\\:\\ 0\\.025441145824111142\ \(0\)\
\-\ embryonic\\:\\ 0\\.025441145824111142\ \(0\)\
\-\ tunica\\:\\ 0\\.0250688404342505\ \(0\)\
\-\ alpha\\-fetoprotein\\:\\ 0\\.024728952242884756\ \(0\)\
\-\ chemo\\:\\ 0\\.024728952242884756\ \(0\)\
\-\ subcarinal\\:\\ 0\\.024728952242884756\ \(0\)\
\-\ bulky\\:\\ 0\\.02412680114980953\ \(0\)\
\-\ chest\\:\\ 0\\.023961667969424047\ \(0\)\
\-\ tumor\\:\\ 0\\.023346472284501693\ \(0\)\
\-\ beta\\:\\ 0\\.02314510416433724\ \(0\)\
\-\ miu\\/ml\\:\\ 0\\.022933904081250227\ \(0\)\
\-\ 10\\-15\\:\\ 0\\.022733539650048856\ \(0\)\
\-\ ng\\/ml\\:\\ 0\\.022187594562645893\ \(0\)\
\-\ respond\\:\\ 0\\.022187594562645893\ \(0\)\
\-\ orchiectomy\\:\\ 0\\.021708679241972718\ \(0\)\
\-\ \\-\\:\\ 0\\.021465567875488634\ \(0\)\
\-\ path\\:\\ 0\\.021149691571501338\ \(0\)\
\-\ ldh\\:\\ 0\\.0208975879733077\ \(0\)\
\-\ stromal\\:\\ 0\\.020777386181640694\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.02054754047842611\ \(0\)\
\-\ days\\:\\ 0\\.020461517938843574\ \(0\)\
\-\ u\\/l\\:\\ 0\\.02033047074735263\ \(0\)\
\-\ usually\\:\\ 0\\.020272876983334055\ \(0\)\
\-\ confined\\:\\ 0\\.020124831163425203\ \(0\)\
\-\ cancers\\:\\ 0\\.020124831163425203\ \(0\)\
\-\ renal\\:\\ 0\\.020058402730141166\ \(0\)\
\-\ abdomen\\:\\ 0\\.019776439553872628\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.019653628086125925\ \(0\)\
\-\ groin\\:\\ 0\\.01939597977443922\ \(0\)\
\-\ staging\\:\\ 0\\.019233195804124498\ \(0\)\
\-\ hcg\\:\\ 0\\.018781973588804794\ \(0\)\
\-\ hard\\:\\ 0\\.018377517811692137\ \(0\)\
\-\ unless\\:\\ 0\\.018069780007578407\ \(0\)\
\-\ cell\\:\\ 0\\.01803313055923036\ \(0\)\
\-\ well\\-circumscribed\\:\\ 0\\.017676011651633232\ \(0\)\
\-\ \\:\\:\\ 0\\.01766054399985414\ \(0\)\
\-\ shunt\\:\\ 0\\.01726980183317992\ \(0\)\
\-\ cns\\:\\ 0\\.017081512372953835\ \(0\)\
\-\ metastatic\\:\\ 0\\.016805542215750705\ \(0\)\
\-\ values\\:\\ 0\\.01668837360037693\ \(0\)\
\-\ dissection\\:\\ 0\\.016407804324707963\ \(0\)\
\-\ components\\:\\ 0\\.016369318791727448\ \(0\)\
\-\ lab\\:\\ 0\\.01633120873334712\ \(0\)\
\-\ \\%\\:\\ 0\\.015572820573015685\ \(0\)\
\-\ local\\:\\ 0\\.015332692561502909\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.01521694335210302\ \(0\)\
\-\ nodes\\:\\ 0\\.015076919399864209\ \(0\)\
\-\ poor\\:\\ 0\\.015022285642150381\ \(0\)\
\-\ there\\:\\ 0\\.014902916677324086\ \(0\)\
\-\ adenopathy\\:\\ 0\\.014862824726055634\ \(0\)\
\-\ metastases\\:\\ 0\\.014260673632980407\ \(0\)\
\-\ stage\\:\\ 0\\.014238415738001354\ \(0\)\
\-\ screening\\:\\ 0\\.014238415738001354\ \(0\)\
\-\ but\\:\\ 0\\.014238307039324513\ \(0\)\
\-\ suggest\\:\\ 0\\.014216283950752613\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.014194276850290677\ \(0\)\
\-\ before\\:\\ 0\\.014128989815237003\ \(0\)\
\-\ involved\\:\\ 0\\.014001600809030904\ \(0\)\
\-\ drainage\\:\\ 0\\.013960044566042405\ \(0\)\
\-\ nodules\\:\\ 0\\.013837964317979498\ \(0\)\
\-\ arising\\:\\ 0\\.013817983455999926\ \(0\)\
\-\ increasing\\:\\ 0\\.013680907987987151\ \(0\)\
\-\ includes\\:\\ 0\\.013456564046245451\ \(0\)\
\-\ solid\\:\\ 0\\.013313854111353045\ \(0\)\
\-\ system\\:\\ 0\\.013142499884378116\ \(0\)\
\-\ film\\:\\ 0\\.012820816153277258\ \(0\)\
\-\ studies\\:\\ 0\\.012466800460074843\ \(0\)\
\-\ ago\\:\\ 0\\.012424721956239252\ \(0\)\
\-\ risk\\:\\ 0\\.012090650966246431\ \(0\)\
\-\ 20\\:\\ 0\\.012002012641238343\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.011964631973206505\ \(0\)\
\-\ left\\:\\ 0\\.01120435862429197\ \(0\)\
\-\ followed\\:\\ 0\\.011190921372573326\ \(0\)\
\-\ swelling\\:\\ 0\\.011120354937426299\ \(0\)\
\-\ initial\\:\\ 0\\.011060867747184797\ \(0\)\
\-\ back\\:\\ 0\\.011011977872451083\ \(0\)\
\-\ cancer\\:\\ 0\\.010973301813924865\ \(0\)\
\-\ show\\:\\ 0\\.010246702869107914\ \(0\)\
\-\ brain\\:\\ 0\\.010044341887901414\ \(0\)\
\-\ ultrasound\\:\\ 0\\.009902822597680872\ \(0\)\
\-\ from\\:\\ 0\\.009894029009017284\ \(0\)\
\-\ y\\.o\\:\\ 0\\.009634294658541797\ \(0\)\
\-\ cystic\\:\\ 0\\.009627471512702181\ \(0\)\
\-\ his\\:\\ 0\\.009620660264245828\ \(0\)\
\-\ two\\:\\ 0\\.009559887646937522\ \(0\)\
\-\ lymphoma\\:\\ 0\\.009539838415583929\ \(0\)\
\-\ all\\:\\ 0\\.00944110738059098\ \(0\)\
\-\ likely\\:\\ 0\\.009415195179436158\ \(0\)\
\-\ ct\\:\\ 0\\.009338309792125335\ \(0\)\
\-\ 4\\:\\ 0\\.009300671504605645\ \(0\)\
\-\ trauma\\:\\ 0\\.00912894055374191\ \(0\)\
\-\ therapy\\:\\ 0\\.008924378110314895\ \(0\)\
\-\ these\\:\\ 0\\.008686893327960313\ \(0\)\
\-\ abdominal\\:\\ 0\\.008343434523914513\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.008203652490749285\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.008045896492118136\ \(0\)\
\-\ man\\:\\ 0\\.00789426501207031\ \(0\)\
\-\ imaging\\:\\ 0\\.007820600876779698\ \(0\)\
\-\ and\\:\\ 0\\.007734761965056262\ \(0\)\
\-\ can\\:\\ 0\\.007571181064332303\ \(0\)\
\-\ findings\\:\\ 0\\.00710483178042953\ \(0\)\
\-\ multiple\\:\\ 0\\.007030492201090894\ \(0\)\
\-\ presents\\:\\ 0\\.0068189230293278355\ \(0\)\
\-\ to\\:\\ 0\\.00667293919442166\ \(0\)\
\-\ within\\:\\ 0\\.006367700814008131\ \(0\)\
\-\ \\,\\:\\ 0\\.006344767160561423\ \(0\)\
\-\ for\\:\\ 0\\.005696157411271212\ \(0\)\
\-\ \\(\\:\\ 0\\.00564345098628016\ \(0\)\
\-\ \\)\\:\\ 0\\.005574513219635196\ \(0\)\
\-\ by\\:\\ 0\\.005558089465800292\ \(0\)\
\-\ be\\:\\ 0\\.005147487200562223\ \(0\)\
\-\ the\\:\\ 0\\.004860326415361845\ \(0\)\
\-\ mass\\:\\ 0\\.004642425808388924\ \(0\)\
\-\ are\\:\\ 0\\.004550288564568757\ \(0\)\
\-\ is\\:\\ 0\\.004392896706130669\ \(0\)\
\-\ pain\\:\\ 0\\.0040765944044169325\ \(0\)\
\-\ was\\:\\ 0\\.003860459071147214\ \(0\)\
\-\ this\\:\\ 0\\.003754442239508332\ \(0\)\
\-\ no\\:\\ 0\\.0033611099636867265\ \(0\)\
\-\ with\\:\\ 0\\.002285237814255659\ \(0\)\
\-\ of\\:\\ 0\\.0022754648593357116\ \(0\)\
\-\ \\.\\:\\ 0\\.0018027108174433655\ \(0\)\
\-\ a\\:\\ 0\\.0015492179758539112\ \(0\)\
